Developer docs
API playgroundTry for free, no card

Search company profiles

Aviva Systems Biology

Full company profile

uuid000h3ff

Namestring
Aviva Systems Biology
Legal namestring
Aviva Systems Biology Corporation
Websiteurl
avivasysbio.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Aviva Systems Biology is a privately held life science reagent company founded in 2002 and headquartered in San Diego, California, that manufactures and distributes antibodies, recombinant proteins, ELISA kits, peptides, and Western blot reagents to the global research community. The company operates one of the broader catalogs in the research-reagent segment, with nearly 500,000 SKUs spanning 20,000+ validated ELISA kits, 20,000+ polyclonal antibodies, and 2,500+ recombinant proteins produced via proprietary E. coli, mammalian, and yeast expression systems. Its technology stack includes the Carterra LSA high-throughput SPR platform for kinetic antibody screening (up to 1,152 monoclonal antibodies in parallel), proprietary ASB® Fluor conjugation chemistry for direct-labeled IHC/IF applications, and Chicken IgY antibody development capability. Through its wholly-owned subsidiary Genway Biotech, Aviva maintains ISO 13485 accreditation enabling custom manufacturing for FDA-regulated and CE-mark in vitro diagnostic products.

The company serves three primary customer segments: academic and research institutions (its largest base), pharmaceutical and biotech companies (custom antibody development, recombinant protein production, ELISA development), and diagnostic manufacturers (regulated ISO 13485/CMO services). Revenue is generated through one-time catalog product sales priced at $115-$949 per unit, custom services engagements priced on a project basis, and a custom conjugation service at $100 per reaction. Distribution runs through a direct e-commerce storefront, a global distributor network, and event-driven scientific conference engagement (AACR, AAIC, AbVal). The company is led by President Kevin Harvey, PhD, with founder Julian Yuan also identified in leadership.

Recent strategic activity in 2025 includes product launches targeting neurodegenerative disease biomarkers (Tau ELISA Kits, Progranulin ELISA Kit) and new ECL substrate formulations, alongside first-time presence at AAIC signaling neuroscience vertical expansion. Aviva is wholly founder/principal-owned with no disclosed external funding rounds and operates within an 11-50 employee band.

Short descriptiontext

Aviva Systems Biology is a privately held San Diego-based life science reagent company founded in 2002 that sells antibodies, recombinant proteins, ELISA kits, peptides, and Western blot reagents to academic researchers, pharmaceutical/biotech firms, and diagnostic manufacturers globally through catalog and custom services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research antibodies, ELISA kits, recombinant proteins, custom antibody production, life science reagents
Industry3 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
  • Medicinal Chemicals & Botanical Products2833
Product category
Life Science Research Reagents
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research Products Sales
TypeOne Time License
Description

Sale of catalog products including antibodies (polyclonal, monoclonal, recombinant), ELISA kits, recombinant proteins, peptides, and Western blot reagents. Products sold directly through e-commerce website with pricing ranging from $115 to $949+ per unit.

avivasysbio.com
2Custom Services
TypeProfessional Services
Description

Custom antibody development, recombinant protein production, ELISA development, and high-throughput antibody characterization services. Includes ISO 13485/CMO services for regulated products.

avivasysbio.com
3Conjugation Services
TypeProfessional Services
Description

Antibody conjugation services for labeling with various fluorophores, biotin, and HRP for $100 per conjugation.

avivasysbio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Pricing details8 tiers
1Tau ELISA Kits - Total and Phospho-Tau assays
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Tau ELISA Kit (Human) OKGD00201: $949.00 for 96 Wells; Phospho-Tau (Thr181) ELISA Kit OKGD00202: $949.00 for 96 Wells; Phospho-Tau (Thr231) ELISA Kit OKGD00203: $949.00 for 96 Wells. All offer <2pg/mL sensitivity.

avivasysbio.com
2Progranulin ELISA Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Progranulin ELISA Kit (Human) OKGD00204: $649.00 for 96 Wells. Sensitivity: 3.04 pg/mL, Assay Range: 4.88-20,000 pg/mL.

avivasysbio.com
3Recombinant Monoclonal Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Most recombinant monoclonal antibodies priced at $499.00 for 100ug. Examples include KRAS G12D Mutant Recombinant Antibody, FTO Recombinant Antibody.

avivasysbio.com
4Polyclonal Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Polyclonal antibodies typically priced at $349.00 for 100uL. Examples include BACE1, CAT, HMGB1, UCHL1 polyclonal antibodies.

avivasysbio.com
5HRP-conjugated Secondary Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Goat Anti-Rabbit IgG Antibody HRP: $279.00 for 1.6 mg; Goat Anti-Mouse IgG HRP: $219.00 for 2mg; Donkey Anti-Rabbit IgG HRP: $179.00 for 1mL.

avivasysbio.com
6Epitope Tag Antibodies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

FLAG Tag Antibody: $150.00 for 50ug; GST-tag Antibody: $225.00 for 100ug; GFP Antibody: $169.00 for 25uL; DsRed Antibody: $419.00 for 100uL.

avivasysbio.com
7Peptides
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Blocking peptides typically $189.00 for 50ug. Human proBNP Peptide: $989.00 for 10UG.

avivasysbio.com
8Custom Conjugation Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Conjugation of Aviva antibodies with fluorophores (FITC, ASB series), Biotin-Peg4, or HRP: $100 per conjugation.

avivasysbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Genway Biotech
Description

ISO 13485/GMP compliant subsidiary for development, validation, and production of antibodies and proteins.

avivasysbio.com
+3 more records
Core offering1 text field

Aviva Systems Biology manufactures and sells a catalog of approximately 500,000 life science research products — primarily polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, ELISA kits, recombinant proteins, peptides, and Western blot reagents — alongside custom antibody production, recombinant protein expression, antibody conjugation, ELISA development, and ISO 13485-accredited contract manufacturing services for the research, drug discovery, and diagnostic communities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Successfully produced over 2,500 recombinant proteins
+2 more records
Product overview1 text field

Aviva Systems Biology is a life science company offering a comprehensive portfolio of antibody-based research products and custom services. The product portfolio includes over 20,000 ELISA Kits, Polyclonal Antibodies, Monoclonal Antibodies, Recombinant Monoclonal Antibodies, Secondary Antibodies, Recombinant Proteins, Peptides, Western Blot Reagents (AvivaBlot™ ECL Substrates), Epitope Tag Antibodies, and Sample Preparation Reagents. Custom services encompass High Throughput Antibody Characterization (SPR-based), Custom Antibody Production (Chicken IgY, Rabbit IgG, Phospho-Specific, Recombinant mAb), Custom Recombinant Protein Production (E. coli, Mammalian, Yeast), ELISA Development, Custom Conjugation, and ISO 13485/CMO Services for regulated diagnostics. Research areas span Cancer, Cardiovascular, Cell Biology, Developmental Biology, Epigenetics, Immunology, Infectious Disease, Metabolism, Neuroscience, Organelle Markers, Signaling Pathways, and Veterinary Sciences.

Product and service2 records
1ELISA Kits
CategoryImmunoassay Kits
Description

Over 20,000 validated ELISA kits for detecting proteins and biomarkers across multiple species, including high-sensitivity and chemiluminescent formats. Sold to academic, biotech, pharma, and diagnostic manufacturer customers.

2Polyclonal Antibodies
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Aviva Systems Biology uses Carterra LSA (Label-free SPR Array) technology for high-throughput antibody characterization services. The partnership enables kinetically screening up to 1,152 mAbs and 384 clones simultaneously, with <200µL sample usage per interactant. Carterra's technology supports Aviva's antibody validation and characterization services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Antibody, ELISA kit, and recombinant protein supplier now under Bio-Techne, serving academic and pharma researchers across similar research areas. Directly comparable catalog structure with the backing of a much larger parent.

TypeDirect peer
Description

Antibody manufacturer known for proprietary antibodies with strong validation data, serving academic and biotech researchers. Closely comparable product positioning, with emphasis on validation rigor similar to Aviva's Enhanced Validation program.

TypeDirect peer
Description

One of the largest antibody reagent suppliers globally (now part of Danaher), offering polyclonal, monoclonal, and recombinant antibodies plus ELISA kits. Directly comparable to Aviva's catalog model with much larger scale and broader geographic reach.

TypeDirect peer
Description

Leading US-based antibody and ELISA kit supplier focused on signaling pathway and cancer/neuroscience research. Closely comparable catalog, validation rigor, and customer base to Aviva's premium research offering.

TypeBroad incumbent
Description

Largest life science tools provider offering Invitrogen and Thermo Scientific branded antibodies, ELISA kits, and proteins across all major research areas. Represents the dominant broad incumbent Aviva competes against for institutional accounts.

TypeDirect peer
Description

Privately held US antibody and immunoassay reagent manufacturer with custom antibody and conjugation services. Comparable mid-sized private competitor with similar catalog + custom service mix.

TypeBroad incumbent
Description

Major life science reagent supplier providing antibodies, ELISA kits, proteins, and peptides as part of Merck's broader life science portfolio. Overlaps with Aviva's catalog across most product categories with significantly greater scale and distribution.

TypeBroad incumbent
Description

Large life science tools company offering antibodies, ELISA kits, and recombinant proteins as part of a wider portfolio spanning instruments and clinical diagnostics. Overlaps with Aviva's catalog but at significantly larger scale and broader scope.

TypeDirect peer
Description

Global biotech offering custom antibody and recombinant protein services plus catalog reagents, serving pharma/biotech/academic customers. Comparable custom services and catalog overlap with Aviva's Protein on Demand and custom antibody offerings.

10Santa Cruz Biotechnology
TypeDirect peer
Description

Long-established broad-portfolio antibody and reagent supplier targeting academic and biotech researchers. Closely matches Aviva's polyclonal/monoclonal breadth and catalog-led distribution model.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aviva Systems Biology

Life Science Research Reagentsavivasysbio.com

Aviva Systems Biology is a privately held San Diego-based life science reagent company founded in 2002 that sells antibodies, recombinant proteins, ELISA kits, peptides, and Western blot reagents to academic researchers, pharmaceutical/biotech firms, and diagnostic manufacturers globally through catalog and custom services.

What Aviva Systems Biology does

Aviva Systems Biology is a privately held life science reagent company founded in 2002 and headquartered in San Diego, California, that manufactures and distributes antibodies, recombinant proteins, ELISA kits, peptides, and Western blot reagents to the global research community. The company operates one of the broader catalogs in the research-reagent segment, with nearly 500,000 SKUs spanning 20,000+ validated ELISA kits, 20,000+ polyclonal antibodies, and 2,500+ recombinant proteins produced via proprietary E. coli, mammalian, and yeast expression systems. Its technology stack includes the Carterra LSA high-throughput SPR platform for kinetic antibody screening (up to 1,152 monoclonal antibodies in parallel), proprietary ASB® Fluor conjugation chemistry for direct-labeled IHC/IF applications, and Chicken IgY antibody development capability. Through its wholly-owned subsidiary Genway Biotech, Aviva maintains ISO 13485 accreditation enabling custom manufacturing for FDA-regulated and CE-mark in vitro diagnostic products.

The company serves three primary customer segments: academic and research institutions (its largest base), pharmaceutical and biotech companies (custom antibody development, recombinant protein production, ELISA development), and diagnostic manufacturers (regulated ISO 13485/CMO services). Revenue is generated through one-time catalog product sales priced at $115-$949 per unit, custom services engagements priced on a project basis, and a custom conjugation service at $100 per reaction. Distribution runs through a direct e-commerce storefront, a global distributor network, and event-driven scientific conference engagement (AACR, AAIC, AbVal). The company is led by President Kevin Harvey, PhD, with founder Julian Yuan also identified in leadership.

Recent strategic activity in 2025 includes product launches targeting neurodegenerative disease biomarkers (Tau ELISA Kits, Progranulin ELISA Kit) and new ECL substrate formulations, alongside first-time presence at AAIC signaling neuroscience vertical expansion. Aviva is wholly founder/principal-owned with no disclosed external funding rounds and operates within an 11-50 employee band.

Aviva Systems Biology firmographics

Firmographics
Name
Aviva Systems Biology
Legal name
Aviva Systems Biology Corporation
Website
https://avivasysbio.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Aviva Systems Biology is a privately held San Diego-based life science reagent company founded in 2002 that sells antibodies, recombinant proteins, ELISA kits, peptides, and Western blot reagents to academic researchers, pharmaceutical/biotech firms, and diagnostic manufacturers globally through catalog and custom services.
Ownership category
akta.pro rank

Aviva Systems Biology industry classification

Industry
Product category
Life Science Research Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Research antibodies
  • ELISA kits
  • Recombinant proteins
  • Custom antibody production
  • Life science reagents

Where Aviva Systems Biology is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Aviva Systems Biology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Research Products Sales: Sale of catalog products including antibodies (polyclonal, monoclonal, recombinant), ELISA kits, recombinant proteins, peptides, and Western blot reagents. Products sold directly through e-commerce website with pricing ranging from $115 to $949+ per unit.
  2. Custom Services: Custom antibody development, recombinant protein production, ELISA development, and high-throughput antibody characterization services. Includes ISO 13485/CMO services for regulated products.
  3. Conjugation Services: Antibody conjugation services for labeling with various fluorophores, biotin, and HRP for $100 per conjugation.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goTau ELISA Kits - Total and Phospho-Tau assays
Unit PricingPay-as-you-goProgranulin ELISA Kit
Unit PricingPay-as-you-goRecombinant Monoclonal Antibodies
Unit PricingPay-as-you-goPolyclonal Antibodies
Unit PricingPay-as-you-goHRP-conjugated Secondary Antibodies
Unit PricingPay-as-you-goEpitope Tag Antibodies
Unit PricingPay-as-you-goPeptides
Unit PricingPay-as-you-goCustom Conjugation Services

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Aviva Systems Biology product offering

Product offering

Core offering

Aviva Systems Biology manufactures and sells a catalog of approximately 500,000 life science research products — primarily polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, ELISA kits, recombinant proteins, peptides, and Western blot reagents — alongside custom antibody production, recombinant protein expression, antibody conjugation, ELISA development, and ISO 13485-accredited contract manufacturing services for the research, drug discovery, and diagnostic communities.

Product overview

Aviva Systems Biology is a life science company offering a comprehensive portfolio of antibody-based research products and custom services. The product portfolio includes over 20,000 ELISA Kits, Polyclonal Antibodies, Monoclonal Antibodies, Recombinant Monoclonal Antibodies, Secondary Antibodies, Recombinant Proteins, Peptides, Western Blot Reagents (AvivaBlot™ ECL Substrates), Epitope Tag Antibodies, and Sample Preparation Reagents. Custom services encompass High Throughput Antibody Characterization (SPR-based), Custom Antibody Production (Chicken IgY, Rabbit IgG, Phospho-Specific, Recombinant mAb), Custom Recombinant Protein Production (E. coli, Mammalian, Yeast), ELISA Development, Custom Conjugation, and ISO 13485/CMO Services for regulated diagnostics. Research areas span Cancer, Cardiovascular, Cell Biology, Developmental Biology, Epigenetics, Immunology, Infectious Disease, Metabolism, Neuroscience, Organelle Markers, Signaling Pathways, and Veterinary Sciences.

Differentiator

Problem solved

Functional benefit

Brands

  • Genway Biotech: ISO 13485/GMP compliant subsidiary for development, validation, and production of antibodies and proteins.
  • ASB Flours
  • AvivaBlot
  • Protein on Demand

Products and services

  • ELISA Kits Over 20,000 validated ELISA kits for detecting proteins and biomarkers across multiple species, including high-sensitivity and chemiluminescent formats. Sold to academic, biotech, pharma, and diagnostic manufacturer customers.
  • Polyclonal Antibodies

Quantifiable outcome

  • Successfully produced over 2,500 recombinant proteins
  • +2 more outcomes

Companies that use Aviva Systems Biology

Customer profile

Segments3 records

Ideal customer profiles3 records

Aviva Systems Biology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Aviva Systems Biology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CarterracoreTechnology or IntegrationAviva Systems Biology uses Carterra LSA (Label-free SPR Array) technology for high-throughput antibody characterization services. The partnership enables kinetically screening up to 1,152 mAbs and 384 clones simultaneously, with <200µL sample usage per interactant. Carterra's technology supports Aviva's antibody validation and characterization services.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Aviva Systems Biology competitors and assessment

Company assessment

Direct peers

  • Novus Biologicals (Bio-Techne): Antibody, ELISA kit, and recombinant protein supplier now under Bio-Techne, serving academic and pharma researchers across similar research areas. Directly comparable catalog structure with the backing of a much larger parent.
  • Proteintech: Antibody manufacturer known for proprietary antibodies with strong validation data, serving academic and biotech researchers. Closely comparable product positioning, with emphasis on validation rigor similar to Aviva's Enhanced Validation program.
  • Abcam: One of the largest antibody reagent suppliers globally (now part of Danaher), offering polyclonal, monoclonal, and recombinant antibodies plus ELISA kits. Directly comparable to Aviva's catalog model with much larger scale and broader geographic reach.
  • Cell Signaling Technology: Leading US-based antibody and ELISA kit supplier focused on signaling pathway and cancer/neuroscience research. Closely comparable catalog, validation rigor, and customer base to Aviva's premium research offering.
  • Rockland Immunochemicals: Privately held US antibody and immunoassay reagent manufacturer with custom antibody and conjugation services. Comparable mid-sized private competitor with similar catalog + custom service mix.
  • GenScript: Global biotech offering custom antibody and recombinant protein services plus catalog reagents, serving pharma/biotech/academic customers. Comparable custom services and catalog overlap with Aviva's Protein on Demand and custom antibody offerings.
  • Santa Cruz Biotechnology: Long-established broad-portfolio antibody and reagent supplier targeting academic and biotech researchers. Closely matches Aviva's polyclonal/monoclonal breadth and catalog-led distribution model.

Broad incumbents

  • Thermo Fisher Scientific (Life Sciences): Largest life science tools provider offering Invitrogen and Thermo Scientific branded antibodies, ELISA kits, and proteins across all major research areas. Represents the dominant broad incumbent Aviva competes against for institutional accounts.
  • Merck Millipore Sigma: Major life science reagent supplier providing antibodies, ELISA kits, proteins, and peptides as part of Merck's broader life science portfolio. Overlaps with Aviva's catalog across most product categories with significantly greater scale and distribution.
  • Bio-Rad Laboratories: Large life science tools company offering antibodies, ELISA kits, and recombinant proteins as part of a wider portfolio spanning instruments and clinical diagnostics. Overlaps with Aviva's catalog but at significantly larger scale and broader scope.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aviva Systems Biology social profiles

Digital presence

Aviva Systems Biology compliance and trust

Trust signal

Compliance1 record

Aviva Systems Biology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aviva Systems Biology leadership team

Management profile

Number of profiles

Profiles2 records

Aviva Systems Biology subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Aviva Systems Biology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aviva Systems Biology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aviva Systems Biology

What does Aviva Systems Biology do?

Aviva Systems Biology manufactures and sells a catalog of approximately 500,000 life science research products — primarily polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, ELISA kits, recombinant proteins, peptides, and Western blot reagents — alongside custom antibody production, recombinant protein expression, antibody conjugation, ELISA development, and ISO 13485-accredited contract manufacturing services for the research, drug discovery, and diagnostic communities.

When was Aviva Systems Biology founded?

Aviva Systems Biology was founded in 2002. It employs 51 to 100 people.

Where is Aviva Systems Biology based?

Aviva Systems Biology is headquartered in San Diego, United States, in the North America region.

How does Aviva Systems Biology make money?

Three revenue lines are on record. Research Products Sales are the primary driver. The others are custom Services and conjugation Services.

Who are Aviva Systems Biology's main competitors?

Direct peers on record are Novus Biologicals (Bio-Techne), Proteintech, Abcam, Cell Signaling Technology, Rockland Immunochemicals, GenScript and Santa Cruz Biotechnology. Broad incumbents are Thermo Fisher Scientific (Life Sciences), Merck Millipore Sigma and Bio-Rad Laboratories.

Does Aviva Systems Biology have an API?

No public API is recorded for Aviva Systems Biology.

What industry is Aviva Systems Biology in?

Aviva Systems Biology's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogQuantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare ConferenceQuantum-Si began commercial shipments of its Platinum protein sequencing system and announced partnerships with Aviva Systems Biology and Biovista. The company reaffirmed its commitment to fiscal discipline and seeks to extend cash runway beyond 2024. It will present business updates at the 41st Annual J.P. Morgan Healthcare Conference on January 12.PR NewswireAviva Systems Biology Launches AvivaBlot ECL Reagents for Western BlotAviva Systems Biology launched AvivaBlot ECL reagents for western blot detection, offering three sensitivity ranges from picogram to low femtogram. The reagents are designed for easy use and affordability, supporting the company's 20-year history in western blot antibodies.PR NewswireAviva Systems Biology Joins YCharOS, Inc. Industry Advisory Committee to Evaluate Antibody ReagentsAviva Systems Biology joined YCharOS's Industry Advisory Committee to help evaluate antibody reagents. Aviva will provide antibodies for YCharOS's head-to-head comparisons of commercially available antibodies to the same target protein. The initiative aims to address inconsistent antibody performance and the reproducibility crisis in biomedical research.PR NewswireAviva Systems Biology Announces the Launch of Protein on Demand™ Semi-Custom Recombinant Protein PortfolioAviva Systems Biology announced the launch of its new Protein on Demand™ semi-custom recombinant protein portfolio, offering over 300,000 proteins for life science research. This service allows researchers to customize proteins with specific tags and expression systems in small-scale quantities ranging from 20 ug to 1 mg. The launch aims to address the needs of academic labs and small biotechs that require flexible production options beyond off-the-shelf limits or large-scale custom suppliers.PR NewswireGlobal Rabies Diagnostics Markets, 2019-2025 - Key Players are Bio-Rad Laboratories, Merck, Aviva Systems Biology, and Creative DiagnosticsResearch and Markets has added a new report on the global rabies diagnostics market, projecting it to reach USD 2.03 billion by 2025 with a CAGR of 4.1%. The market growth is driven by diagnostic assays that support disease control programs and partnerships such as the United Against Rabies Collaboration involving WHO and FAO. Key companies identified in the competitive landscape include Bio-Rad Laboratories, Merck KGaA, Aviva Systems Biology, and Creative Diagnostics.PR NewswireThe global rabies diagnostics market size is expected to reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1% during the forecast periodAccording to a Grand View Research report, the global rabies diagnostics market is expected to reach USD 2.03 billion by 2025, growing at a CAGR of 4.1% during the forecast period, driven by increasing adoption of diagnostic testing kits for disease control and eradication programs. The report highlights partnerships such as the United Against Rabies Collaboration involving WHO, OIE, GARC, and FAO, along with public health initiatives in regions like Montana, U.S. Key companies operating in this market include Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, and Creative Diagnostics.PR NewswireAviva Systems Biology Acquires GenWay BiotechAviva Systems Biology Corporation (ASB) announced the acquisition of GenWay Biotech Incorporated, a protein solutions and applications provider serving research and diagnostic markets. GenWay brings 18 years of experience producing proteins, antibodies, and ELISA assays, along with ISO13485 accreditation and clinical laboratory services through a CAP-accredited, CLIA-certified facility. The transaction positions ASB as a leading provider of proteomic solutions with over 50,000 antibodies manufactured to date, while expanding both companies' existing business operations.